Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes
- Author:
Seok Hyeon SONG
1
;
Seung Kook BAEK
;
Min Woo LEE
;
Young Hoon LEE
Author Information
- Publication Type:Original Article
- Keywords: Bromfenac; Cataract; Diabetes mellitus; Macular edema; Nonsteroidal anti-inflammatory agents
- MeSH: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diabetes Mellitus; Humans; Macular Edema; Retrospective Studies; Sodium; Visual Acuity
- From:Korean Journal of Ophthalmology 2020;34(1):46-55
- CountryRepublic of Korea
- Language:English
- Abstract: 0.05). Mean changes in central macular thickness showed significant differences at 1 and 4 months postoperatively (−1.44 ± 11.72 and 10.44 ± 22.48 µm in bromfenac group vs. 47.19 ± 70.24 and 31.69 ± 48.04 µm in control group, p < 0.001 and p = 0.016) and mean changes in macular volume showed a significant difference at 1 month postoperatively (−0.08 ± 0.47 mm³ in bromfenac group vs. 0.58 ± 1.28 mm³ in control group, p < 0.001). There were no significant differences thereafter (p > 0.05).CONCLUSIONS: Treatment with 0.1% bromfenac sodium hydrate ophthalmic solution showed good efficacy for preventing cystoid macular edema early after cataract surgery in patients with diabetes.]]>
